I still don't get comments like this along with highlighting all the success from the Janssen collaboration when in turn they walked from it. It's all well and good with the line that it was just due to Janssen changing strategic priorities (although it was always the line of "restructures" to excuse no deals being inked in years past) but it's hard to fathom they would let it go there if it was making so much ground with lines like "best in class" and "breakthrough" status ?
It's positive to see Genentech come back though after walking from the last deal a year or so earlier which maybe says Janssen may follow that same path and come back again at a later date.
Maybe this next year ahead will be the one.
PYC Price at posting:
1.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)